Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.37 USD | -1.17% | -3.44% | +51.80% |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
04-16 | NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.35M 188M |
---|---|---|---|---|---|
Net income 2022 | -62M -4.96B | Net income 2023 | -32M -2.56B | EV / Sales 2022 | - |
Net cash position 2022 | 33.62M 2.69B | Net cash position 2023 | 3.13M 251M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.09
x | P/E ratio 2023 |
-0.07
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.29% |
1 day | -1.17% | ||
1 week | -3.44% | ||
Current month | -39.93% | ||
1 month | -38.84% | ||
3 months | -37.01% | ||
6 months | -18.60% | ||
Current year | +51.80% |
Managers | Title | Age | Since |
---|---|---|---|
Kristi Jones
CEO | Chief Executive Officer | 60 | 31/05/17 |
Mathias Oelke
FOU | Founder | 56 | 06/06/11 |
Tonya Catterton
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sol Barer
CHM | Chairman | 76 | 15/12/19 |
Zheng Bin Yao
BRD | Director/Board Member | 58 | 31/12/16 |
Alan S. Roemer
BRD | Director/Board Member | 54 | 31/01/17 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 3.37 | -1.17% | 3,391 |
25/04/24 | 3.41 | +4.60% | 7,330 |
24/04/24 | 3.26 | -4.96% | 12,753 |
23/04/24 | 3.43 | -5.90% | 6,785 |
22/04/24 | 3.645 | +4.44% | 45,019 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+51.80% | 4.62M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NEXI Stock